Streetbeat News

Products Services

MYGN

Myriad Genetics partners with Ultima Genomics to explore the UG 100 sequencing platform, aiming to enhance clinical test offerings in oncology and reproductive genomics. The collaboration focuses on improving Myriad's Precise MRD test and launching the FirstGene Multiple Prenatal Screen.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2024 | 1:01 pm

NFLX

TSM

Direxion has launched new leveraged and inverse ETFs targeting Netflix and TSMC, designed for short-term, high-risk trading. These ETFs allow traders to magnify their positions on daily stock movements, appealing to those looking for tactical trading opportunities.

Portfolio Pulse from Surbhi Jain

October 03, 2024 | 1:00 pm

SBUX

Starbucks is expanding its coffee innovation network by investing in new farms in Guatemala and Costa Rica, with plans for future investments in Africa and Asia. These efforts aim to enhance coffee farming's productivity, profitability, and climate resilience amid climate change challenges.

Portfolio Pulse from Akanksha Bakshi

October 03, 2024 | 12:59 pm

SMH

SOXX

TSM

Taiwan Semiconductor Manufacturing Co (TSM) and other global semiconductor manufacturers are monitoring quartz supplies after Hurricane Helene halted production at key mines. TSM is considering discounts to boost capacity utilization amid competition. Semiconductor ETFs have seen a decline due to industry selloff.

Portfolio Pulse from Anusuya Lahiri

October 03, 2024 | 12:55 pm

AIM

AIM ImmunoTech shares rose following the announcement of a new U.S. patent for Ampligen, aimed at treating endometriosis.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2024 | 12:48 pm

AIM

AIM ImmunoTech has been granted U.S. Patent No. 12,102,649 for its drug Ampligen, which is intended for the treatment of endometriosis. This patent could potentially enhance AIM ImmunoTech's market position and future revenue streams.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2024 | 12:46 pm

LPTH

LightPath Technologies has received $0.5 million in Phase 2 funding from the U.S. Defense Department to qualify additional BlackDiamond glasses as substitutes for germanium. This follows a successful Phase 1 where three materials were qualified. Phase 2 will cover six more materials advancing to MRL-9 for defense applications.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2024 | 12:45 pm

EVGO

EVgo Inc. has received a conditional commitment for a $1.05 billion loan guarantee from the U.S. Department of Energy to expand its fast charging network across the U.S. This financing will support the construction of approximately 7,500 new DC fast charging stalls.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2024 | 12:41 pm

EVGO

EVgo has received a $1.05 billion conditional commitment for a DOE loan guarantee to expand its public fast charging network across the U.S. This financing will aid in constructing around 7,500 new DC fast charging stalls in community locations.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2024 | 12:40 pm

ATNF

180 Life Sciences Corp. (NASDAQ:ATNF) has announced the acquisition of an advanced gaming technology platform, marking a strategic shift into the iGaming market. The company has also made progress on its CBD formulation and strengthened its balance sheet by settling liabilities. The acquisition is expected to help meet Nasdaq's listing requirements and provide a competitive edge in the blockchain casino market.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2024 | 12:40 pm